{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:16:54Z","timestamp":1793891814940,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-024-04123-4","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T17:01:33Z","timestamp":1728925293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vitro cytotoxicity assessment of biosynthesized Apis mellifera bee venom nanoparticles (BVNPs) against MCF-7 breast cancer cell lines"],"prefix":"10.1186","volume":"19","author":[{"given":"Vikram","family":"Jadhav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Bhagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Palake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisan","family":"Kodam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Dhaygude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Kardel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dnyaneshwar","family":"Lokhande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayraj","family":"Aher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"issue":"1","key":"4123_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/0005772X.2004.11099604","volume":"85","author":"E Crane","year":"2004","unstructured":"Crane E. A short history of knowledge about honey bees (Apis) up to 1800. Bee World. 2004;85(1):6\u201311. https:\/\/doi.org\/10.1080\/0005772X.2004.11099604.","journal-title":"Bee World"},{"issue":"14","key":"4123_CR2","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.3390\/cancers15143714","volume":"15","author":"A Ma\u0142ek","year":"2023","unstructured":"Ma\u0142ek A, Strzemski M, Kurzepa J, Kurzepa J. Can bee venom be used as anticancer agent in modern medicine? Cancers. 2023;15(14):3714. https:\/\/doi.org\/10.3390\/cancers15143714.","journal-title":"Cancers"},{"issue":"1","key":"4123_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/abc.2023.131001","volume":"13","author":"P Loukas","year":"2023","unstructured":"Loukas P, Maria T. The application of honeybee products in the health sector. Adv Biol Chem. 2023;13(1):1\u201316. https:\/\/doi.org\/10.4236\/abc.2023.131001.","journal-title":"Adv Biol Chem"},{"key":"4123_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2017.05.010","volume":"402","author":"I Rady","year":"2017","unstructured":"Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;402:16\u201331. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.010.","journal-title":"Cancer Lett"},{"issue":"3","key":"4123_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3831\/KPI.2016.19.023","volume":"19","author":"H Zolfagharian","year":"2016","unstructured":"Zolfagharian H, Mohajeri M, Babaie M. Bee venom (Apis Mellifera) an effective potential alternative to gentamicin for specific bacteria strains: Bee venom an effective potential for bacteria. J Pharmacopuncture. 2016;19(3):225. https:\/\/doi.org\/10.3831\/KPI.2016.19.023.","journal-title":"J Pharmacopuncture"},{"issue":"2","key":"4123_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/vetsci10020119","volume":"10","author":"R Bava","year":"2023","unstructured":"Bava R, Castagna F, Musella V, Lupia C, Palma E, Britti D. Therapeutic Use of Bee venom and potential applications in veterinary medicine. Vet Sci. 2023;10(2):119. https:\/\/doi.org\/10.3390\/vetsci10020119.","journal-title":"Vet Sci"},{"key":"4123_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.toxicon.2019.02.016","volume":"161","author":"A Kocyigit","year":"2019","unstructured":"Kocyigit A, Guler EM, Kaleli S. Anti-inflammatory and antioxidative properties of honey bee venom on Freund\u2019s Complete Adjuvant-induced arthritis model in rats. Toxicon. 2019;161:4\u201311. https:\/\/doi.org\/10.1016\/j.toxicon.2019.02.016.","journal-title":"Toxicon"},{"issue":"42","key":"4123_CR8","doi-asserted-by":"publisher","first-page":"44437","DOI":"10.18632\/oncotarget.6295","volume":"6","author":"J Zheng","year":"2015","unstructured":"Zheng J, Lee HL, Ham YW, Song HS, Song MJ, Hong JT. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B. Oncotarget. 2015;6(42):44437. https:\/\/doi.org\/10.18632\/oncotarget.6295.","journal-title":"Oncotarget"},{"key":"4123_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.toxicon.2018.04.012","volume":"148","author":"S Zhang","year":"2018","unstructured":"Zhang S, Liu Y, Ye Y, Wang XR, Lin LT, Xiao LY, Liu CZ. Bee venom therapy: potential mechanisms and therapeutic applications. Toxicon. 2018;148:64\u201373. https:\/\/doi.org\/10.1016\/j.toxicon.2018.04.012.","journal-title":"Toxicon"},{"issue":"1","key":"4123_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jsps.2022.11.008","volume":"31","author":"A Ullah","year":"2023","unstructured":"Ullah A, Aldakheel FM, Anjum SI, Raza G, Khan SA, Gajger IT. Pharmacological properties and therapeutic potential of honey bee venom. Saudi Pharmac J. 2023;31(1):96\u2013109. https:\/\/doi.org\/10.1016\/j.jsps.2022.11.008.","journal-title":"Saudi Pharmac J"},{"key":"4123_CR11","doi-asserted-by":"crossref","unstructured":"Mashhoor EA, Abd El-Aziz AA, Metwaly AM, Mohammed ES, EL-Sherbini SM. Relationship between the bee venom therapy and tumor necrosis factor-308 variation in the management of rheumatoid arthritis, a prospective study, 2023. https:\/\/digitalcommons.aaru.edu.jo\/isl\/vol12\/iss6\/41","DOI":"10.18576\/isl\/120641"},{"issue":"3","key":"4123_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13596-022-00631-9","volume":"22","author":"M Hong","year":"2022","unstructured":"Hong M, Kang MJ, Pak S, Han IH, Bae H. Bee venom phospholipase A2 ameliorates amyotrophic lateral sclerosis by increasing regulatory T cell population. Adv Trad Med. 2022;22(3):599\u2013606. https:\/\/doi.org\/10.1007\/s13596-022-00631-9.","journal-title":"Adv Trad Med"},{"key":"4123_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biopha.2017.04.065","volume":"91","author":"K Awad","year":"2017","unstructured":"Awad K, Abushouk AI, AbdelKarim AH, Mohammed M, Negida A, Shalash AS. Bee venom for the treatment of Parkinson\u2019s disease: How far is it possible? Biomed Pharmacother. 2017;91:295\u2013302. https:\/\/doi.org\/10.1016\/j.biopha.2017.04.065.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4123_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0476-z","volume":"13","author":"M Ye","year":"2016","unstructured":"Ye M, Chung HS, Lee C, Yoon MS, Yu AR, Kim JS, Bae H. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer\u2019s disease. J Neuroinflamm. 2016;13(1):1\u201312. https:\/\/doi.org\/10.1186\/s12974-016-0476-z.","journal-title":"J Neuroinflamm"},{"issue":"8","key":"4123_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3390\/biomedicines9080992","volume":"9","author":"JY Kim","year":"2021","unstructured":"Kim JY, Jang HJ, Leem J, Kim GM. Protective effects of bee venom-derived phospholipase A2 against cholestatic liver disease in mice. Biomedicines. 2021;9(8):992. https:\/\/doi.org\/10.3390\/biomedicines9080992.","journal-title":"Biomedicines"},{"issue":"06","key":"4123_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1142\/S0192415X10008482","volume":"38","author":"WR Lee","year":"2010","unstructured":"Lee WR, Kim SJ, Park JH, Kim KH, Chang YC, Park YY, Park KK. Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism. Am J Chin Med. 2010;38(06):1077\u201392. https:\/\/doi.org\/10.1142\/S0192415X10008482.","journal-title":"Am J Chin Med"},{"key":"4123_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10555-011-9339-3","volume":"31","author":"N Or\u0161oli\u0107","year":"2012","unstructured":"Or\u0161oli\u0107 N. Bee venom in cancer therapy. Cancer Metastasis Rev. 2012;31:173\u201394. https:\/\/doi.org\/10.1007\/s10555-011-9339-3.","journal-title":"Cancer Metastasis Rev"},{"issue":"14","key":"4123_CR18","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.3390\/nu15143111","volume":"15","author":"P Pandey","year":"2023","unstructured":"Pandey P, Khan F, Khan MA, Kumar R, Upadhyay TK. An updated review summarizing the anticancer efficacy of melittin from bee venom in several models of human cancers. Nutrients. 2023;15(14):3111. https:\/\/doi.org\/10.3390\/nu15143111.","journal-title":"Nutrients"},{"key":"4123_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.glohj.2023.02.008","author":"A Haleem","year":"2023","unstructured":"Haleem A, Javaid M, Singh RP, Rab S, Suman R. Applications of nanotechnology in medical field. Global Health Journal. 2023. https:\/\/doi.org\/10.1016\/j.glohj.2023.02.008.","journal-title":"Global Health Journal"},{"key":"4123_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmrt.2023.09.291","author":"S Kumari","year":"2023","unstructured":"Kumari S, Raturi S, Kulshrestha S, Chauhan K, Dhingra S, Andr\u00e1s K, Singh T. A comprehensive review on various techniques used for synthesizing nanoparticles. J Mater Res Technol. 2023. https:\/\/doi.org\/10.1016\/j.jmrt.2023.09.291.","journal-title":"J Mater Res Technol"},{"issue":"8","key":"4123_CR21","doi-asserted-by":"publisher","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","volume":"15","author":"S Gao","year":"2021","unstructured":"Gao S, Yang X, Xu J, Qiu N, Zhai G. Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment. ACS Nano. 2021;15(8):12567\u2013603. https:\/\/doi.org\/10.1021\/acsnano.1c02103.","journal-title":"ACS Nano"},{"issue":"4","key":"4123_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/molecules23040826","volume":"23","author":"CY Zhao","year":"2018","unstructured":"Zhao CY, Cheng R, Yang Z, Tian ZM. Nanotechnology for cancer therapy based on chemotherapy. Molecules. 2018;23(4):826. https:\/\/doi.org\/10.3390\/molecules23040826.","journal-title":"Molecules"},{"key":"4123_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.colsurfb.2014.12.041","volume":"126","author":"M Estanqueiro","year":"2015","unstructured":"Estanqueiro M, Amaral MH, Concei\u00e7\u00e3o J, Lobo JMS. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf, B. 2015;126:631\u201348. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.12.041.","journal-title":"Colloids Surf, B"},{"key":"4123_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/med.22023","author":"M Taheri","year":"2024","unstructured":"Taheri M, Tehrani HA, Dehghani S, Alibolandi M, Arefian E, Ramezani M. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle. Med Res Rev. 2024. https:\/\/doi.org\/10.1002\/med.22023.","journal-title":"Med Res Rev"},{"issue":"16","key":"4123_CR25","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.1039\/C4CS00363B","volume":"44","author":"H Duan","year":"2015","unstructured":"Duan H, Wang D, Li Y. Green chemistry for nanoparticle synthesis. Chem Soc Rev. 2015;44(16):5778\u201392. https:\/\/doi.org\/10.1039\/C4CS00363B.","journal-title":"Chem Soc Rev"},{"issue":"8","key":"4123_CR26","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1021\/acs.nanolett.0c02738","volume":"20","author":"AE Nel","year":"2020","unstructured":"Nel AE. Transformational impact of nanomedicine: reconciling outcome with promise. Nano Lett. 2020;20(8):5601\u20133. https:\/\/doi.org\/10.1021\/acs.nanolett.0c02738.","journal-title":"Nano Lett"},{"key":"4123_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-981-19-4811-4_2","volume-title":"Phytonanotechnology","author":"VR Jadhav","year":"2022","unstructured":"Jadhav VR, Aher JS, Bhagare AM, Dhaygude AC, Lokhande DD. Plant-Mediated Green Synthesis of Nanoparticles for Photocatalytic Dye Degradation. In: Phytonanotechnology. Singapore: Singapore; 2022. p. 31\u201357. https:\/\/doi.org\/10.1007\/978-981-19-4811-4_2."},{"key":"4123_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2147393","volume":"2022","author":"V Jadhav","year":"2022","unstructured":"Jadhav V, Bhagare A, Ali IH, Dhayagude A, Lokhande D, Aher J, Dutta M. Role of Moringa oleifera on green synthesis of metal\/metal oxide nanomaterials. J Nanomater. 2022;2022:1\u201310. https:\/\/doi.org\/10.1155\/2022\/2147393.","journal-title":"J Nanomater"},{"key":"4123_CR29","unstructured":"Jadhav VR et al. Bee Venom nanoparticles and process to prepare thereof\u00a0(Patent No. 433998). Patent Office: IN, 2023."},{"key":"4123_CR30","unstructured":"Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor L (2016) Cell viability assays.\u00a0Assay guidance manual [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK144065\/"},{"key":"4123_CR31","doi-asserted-by":"publisher","first-page":"104740","DOI":"10.1016\/j.ibiod.2019.104740","volume":"144","author":"RM Tripathi","year":"2019","unstructured":"Tripathi RM, Park SH, Kim G, Kim DH, Ahn D, Kim YM, Chung SJ. Metal-induced redshift of optical spectra of gold nanoparticles: an instant, sensitive, and selective visual detection of lead ions. Int Biodeteriorat Biodegrad. 2019;144:104740. https:\/\/doi.org\/10.1016\/j.ibiod.2019.104740.","journal-title":"Int Biodeteriorat Biodegrad"},{"issue":"10","key":"4123_CR32","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1021\/jp037201k","volume":"108","author":"L Yanhong","year":"2004","unstructured":"Yanhong L, Dejun W, Qidong Z, Min Y, Qinglin Z. A study of quantum confinement properties of photogenerated charges in ZnO nanoparticles by surface photovoltage spectroscopy. J Phys Chem B. 2004;108(10):3202\u20136. https:\/\/doi.org\/10.1021\/jp037201k.","journal-title":"J Phys Chem B"},{"issue":"30","key":"4123_CR33","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1002\/anie.201005120","volume":"50","author":"A Schlossbauer","year":"2011","unstructured":"Schlossbauer A, Dohmen C, Schaffert D, Wagner E, Bein T. pH-responsive release of acetal-linked melittin from SBA-15 mesoporous silica. Angew Chem Int Ed Engl. 2011;50(30):6828\u201330. https:\/\/doi.org\/10.1002\/anie.201005120.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1\u20132","key":"4123_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijpharm.2007.05.056","volume":"345","author":"M Qiao","year":"2007","unstructured":"Qiao M, Chen D, Hao T, Zhao X, Hu H, Ma X. Effect of bee venom peptide\u2013copolymer interactions on thermosensitive hydrogel delivery systems. Int J Pharm. 2007;345(1\u20132):116\u201324. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.05.056.","journal-title":"Int J Pharm"},{"key":"4123_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/B978-0-444-64181-6.00013-9","volume":"60","author":"AA Abd El-Wahed","year":"2019","unstructured":"Abd El-Wahed AA, Khalifa SA, Sheikh BY, Farag MA, Saeed A, Larik FA, El-Seedi HR. Bee venom composition: from chemistry to biological activity. Stud Nat Prod Chem. 2019;60:459\u201384. https:\/\/doi.org\/10.1016\/B978-0-444-64181-6.00013-9.","journal-title":"Stud Nat Prod Chem"},{"issue":"5","key":"4123_CR36","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.bbagen.2018.02.004","volume":"1862","author":"N Krayem","year":"2018","unstructured":"Krayem N, Parsiegla G, Gaussier H, Louati H, Jallouli R, Mansuelle P, Gargouri Y. Functional characterization and FTIR-based 3D modeling of full length and truncated forms of Scorpio maurus venom phospholipase A2. Biochim Biophys Acta Gener Sub. 2018;1862(5):1247\u201361. https:\/\/doi.org\/10.1016\/j.bbagen.2018.02.004.","journal-title":"Biochim Biophys Acta Gener Sub"},{"issue":"13","key":"4123_CR37","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1021\/ja00039a021","volume":"114","author":"BC Potts","year":"1992","unstructured":"Potts BC, Faulkner DJ, De Carvalho MS, Jacobs RS. Chemical mechanism of inactivation of bee venom phospholipase A2 by the marine natural products manoalide, luffariellolide, and scalaradial. J Am Chem Soc. 1992;114(13):5093\u2013100. https:\/\/doi.org\/10.1021\/ja00039a021.","journal-title":"J Am Chem Soc"},{"issue":"7","key":"4123_CR38","doi-asserted-by":"publisher","first-page":"e0131896","DOI":"10.1371\/journal.pone.0131896","volume":"10","author":"NC Anilkumar","year":"2015","unstructured":"Anilkumar NC, Sundaram MS, Mohan CD, Rangappa S, Bulusu KC, Fuchs JE, Rangappa KS. A one pot synthesis of novel bioactive tri-substitute-condensed-imidazopyridines that targets snake venom phospholipase a2. PLoS ONE. 2015;10(7):e0131896. https:\/\/doi.org\/10.1371\/journal.pone.0131896.","journal-title":"PLoS ONE"},{"issue":"1","key":"4123_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.26650\/EurJBiol.2020.0039","volume":"79","author":"N Igc\u0131","year":"2020","unstructured":"Igc\u0131 N, Demiralp FDO. A Fourier transform infrared spectroscopic investigation of macrovipera lebetina lebetina and M.l. obtusa Crude Venoms. Eur J Biol. 2020;79(1):14\u201322. https:\/\/doi.org\/10.26650\/EurJBiol.2020.0039.","journal-title":"Eur J Biol"},{"issue":"10","key":"4123_CR40","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3390\/molecules26103049","volume":"26","author":"I Tanuwidjaja","year":"2021","unstructured":"Tanuwidjaja I, Sve\u010dnjak L, Gugi\u0107 D, Levani\u0107 M, Juri\u0107 S, Vincekovi\u0107 M, Mrkonji\u0107 Fuka M. Chemical profiling and antimicrobial properties of honey bee (Apis mellifera L.) venom. Molecules. 2021;26(10):3049. https:\/\/doi.org\/10.3390\/molecules26103049.","journal-title":"Molecules"},{"issue":"1","key":"4123_CR41","doi-asserted-by":"publisher","first-page":"2785304","DOI":"10.1155\/2020\/2785304","volume":"2020","author":"AI Alalawy","year":"2020","unstructured":"Alalawy AI, El Rabey HA, Almutairi FM, Tayel AA, Al-Duais MA, Zidan NS, Sakran MI. Effectual anticancer potentiality of loaded bee venom onto fungal chitosan nanoparticles. Int J Polym Sci. 2020;2020(1):2785304. https:\/\/doi.org\/10.1155\/2020\/2785304.","journal-title":"Int J Polym Sci"},{"issue":"12","key":"4123_CR42","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/antibiotics10121503","volume":"10","author":"J Maitip","year":"2021","unstructured":"Maitip J, Mookhploy W, Khorndork S, Chantawannakul P. Comparative study of antimicrobial properties of bee venom extracts and melittins of honey bees. Antibiotics. 2021;10(12):1503. https:\/\/doi.org\/10.3390\/antibiotics10121503.","journal-title":"Antibiotics"},{"key":"4123_CR43","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1007\/s00216-015-8578-5","volume":"407","author":"J Tusiimire","year":"2015","unstructured":"Tusiimire J, Wallace J, Dufton M, Parkinson J, Clements CJ, Young L, Watson DG. An LCMS method for the assay of melittin in cosmetic formulations containing bee venom. Anal Bioanal Chem. 2015;407:3627\u201335. https:\/\/doi.org\/10.1007\/s00216-015-8578-5.","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"4123_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ab.2010.05.014","volume":"404","author":"J Zhou","year":"2010","unstructured":"Zhou J, Zhao J, Zhang S, Shen J, Qi Y, Xue X, Chen L. Quantification of melittin and apamin in bee venom lyophilized powder from Apis mellifera by liquid chromatography\u2013diode array detector\u2013tandem mass spectrometry. Anal Biochem. 2010;404(2):171\u20138. https:\/\/doi.org\/10.1016\/j.ab.2010.05.014.","journal-title":"Anal Biochem"},{"issue":"1","key":"4123_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12906-023-03897-x","volume":"23","author":"M Obeidat","year":"2023","unstructured":"Obeidat M, Al-Khraisat IF, Jaradat DSM, Ghanim BY, Abdallah QM, Arqoub DA, Qinna NA. Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line. BMC Complem Med Therap. 2023;23(1):132. https:\/\/doi.org\/10.1186\/s12906-023-03897-x.","journal-title":"BMC Complem Med Therap"},{"issue":"7","key":"4123_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/toxins12070437","volume":"12","author":"S Huang","year":"2020","unstructured":"Huang S, Wang J, Guo Z, Wang Y, Liu C. Quantitative measurement of melittin in Asian honeybee venom using a new method including UPLC-QqTOF-MS. Toxins. 2020;12(7):437. https:\/\/doi.org\/10.3390\/toxins12070437.","journal-title":"Toxins"},{"issue":"6","key":"4123_CR47","doi-asserted-by":"publisher","first-page":"e67297","DOI":"10.1371\/journal.pone.0067297","volume":"8","author":"KL Wang","year":"2013","unstructured":"Wang KL, Hsia SM, Yeh JY, Cheng SC, Wang PS, et al. Anti-proliferative effects of evodiamine on human breast cancer cells. PLoS ONE. 2013;8(6):e67297. https:\/\/doi.org\/10.1371\/journal.pone.0067297.","journal-title":"PLoS ONE"},{"issue":"1","key":"4123_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41698-020-00129-0","volume":"4","author":"C Duffy","year":"2020","unstructured":"Duffy C, Sorolla A, Wang E, Golden E, Woodward E, Davern K, Blancafort P. Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. NPJ Precis Oncol. 2020;4(1):24. https:\/\/doi.org\/10.1038\/s41698-020-00129-0.","journal-title":"NPJ Precis Oncol"},{"key":"4123_CR49","doi-asserted-by":"publisher","first-page":"22092","DOI":"10.1038\/s41598-023-47199-1","volume":"13","author":"HD Nguyen","year":"2023","unstructured":"Nguyen HD, Truong TBN, Huynh Q, Cang Nguyen TTL, Tran LT, Tran LQ. Dang TP TKTt-45, a T-type calcium channel blocker, acts as an anticancer agent by inducing apoptosis on HeLa cervical cancer cell line. Sci Rep. 2023;13:22092. https:\/\/doi.org\/10.1038\/s41598-023-47199-1.","journal-title":"Sci Rep"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-024-04123-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-024-04123-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-024-04123-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T17:01:37Z","timestamp":1728925297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-024-04123-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4123"],"URL":"https:\/\/doi.org\/10.1186\/s11671-024-04123-4","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval was required for this study as it involved no harm to live vertebrates. The use of the human breast cancer cell line MCF-7 was conducted following institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}